Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucelSaurabh Zanwar, Doris K. Hansen, Peter A. Forsberg et al.|Journal of Hematology & Oncology|2024Cited by 46
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple MyelomaOlga Lytvynova, Faiz Anwer, Jenna Jwayyed et al.|Antibodies|2024Cited by 4
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple MyelomaOlga Lytvynova, Faiz Anwer, Jenna Jwayyed et al.|Preprints.org|2024Cited by 2
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologistsAli Mushtaq, Faiz Anwer, Asfand Yar Cheema et al.|Blood Reviews|2025Cited by 2
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate CorrelationDavid R. Kaplan, Jack Khouri|Journal of Cellular and Molecular Medicine|2025Cited by 1